Sei Investments CO Agenus Inc Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.53 - $0.93 $67 - $118	127 Added 0.69%	18,543 $10,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $26,703 - $54,327	18,416 New	18,416 $27,000
Q3 2021 Nov 12, 2021	SELL	$4.98 - $6.63 $303,282 - $403,767	-60,900 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.56 - $5.49 $155,904 - $334,341	60,900 New	60,900 $374,000
Q3 2020 Nov 06, 2020	SELL	$2.98 - $5.2 $210,343 - $367,042	-70,585 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$2.29 - $4.24 $161,639 - $299,280	70,585 New	70,585 $277,000
Q3 2018 Nov 08, 2018	SELL	$1.59 - $2.42 $4,238 - $6,451	-2,666 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$3.48 - $4.44 $9,277 - $11,837	2,666	2,666 $12,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.